NEW YORK, Oct. 1, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Translational Regenerative Medicine: Market Prospects 2012-2022 <\/p>\n
http:\/\/www.reportlinker.com\/p0595030\/Translational-Regenerative-Medicine-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation<\/a> <\/p>\n Report Details <\/p>\n New study shows you commercial potential of regenerative treatments <\/p>\n See what the future holds for translational regenerative medicine. Visiongain's updated report lets you assess forecasted sales at overall world market, submarket, product and regional level to 2022. <\/p>\n There you investigate the most lucrative areas in that research field, industry and market. Discover prospects for tissue-engineered products, stem cell treatments and gene therapy. <\/p>\n We pack our study with information and analysis to help your work and save you time: <\/p>\n Access to present and predicted trends, with commercial opportunities and prospects revealed <\/p>\n Data and discussions - including our revenue forecasts to 2022 - for your research, analyses and decision making <\/p>\n<\/p>\n Read the rest here: <\/p>\n Translational Regenerative Medicine: Market Prospects 2012-2022<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, Oct. Continue reading